Paul F. Truex, President and CEO at Anthera Pharmaceuticals Inc (ANTH), bought 1,000 shares at $7.18 ($7K) on 2010-03-01, disclosed to the SEC on 2010-03-02.
Open-market purchase of $7k ANTH by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.05 | 500 | $4K | 49.5% |
| 2 | $7.18 | 300 | $2K | 30.3% |
| 3 | $7.19 | 200 | $1K | 20.2% |
| Total | $7.12 avg | 1,000 | $7K | 100% |
| Filing → |
| ANTH | BUY | 2012-07-02 | $15K | — | Filing → |
| ANTH | SELL | 2012-02-17 | $118K | — | Filing → |
| ANTH | SELL | 2012-01-19 | $101K | — | Filing → |